CompanyProfilev2Financials
Actions
Jump To:
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2024-12-31 | 2023-12-31 | ||
|---|---|---|---|---|
| Total Assets | 5,125,314 | 5,173,150 | - | - |
| Total Liabilities | 3,451,253 | 3,608,388 | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) | 1,626,109 | 1,519,080 | - | - |
| Total Liabilities and Shareholders Equity | 5,125,314 | 5,173,150 | - | - |
| Statement of Income | 2024-12-31 | 2023-12-31 | ||
| Total Revenue (Sales/Operating) | 2,882,818 | 2,653,170 | - | - |
| Net Profit (Loss) before Zakat and Tax | 308,279 | 198,159 | - | - |
| Zakat and Income Tax | -26,277 | -17,983 | - | - |
| Net Profit (Loss) after Zakat and Tax | 282,002 | 180,176 | - | - |
| Total Comprehensive Income | 306,499 | 154,119 | - | - |
| Profit (Loss) per Share | 3.06 | 1.96 | - | - |
| Cash Flows | 2024-12-31 | 2023-12-31 | ||
| Net Cash From Operating Activities | 939,264 | 191,083 | - | - |
| Net Cash From Investing Activities | -507,294 | -241,989 | - | - |
| Net Cash From Financing Activities | -424,110 | 79,726 | - | - |
| Cash and Cash Equivalents, Beginning of the Period | 44,423 | 15,602 | - | - |
| Cash and Cash Equivalents, End of the Period | 52,283 | 44,423 | - | - |
| All Figures in | Thousands | Thousands | ||
| All Currency In | ^ | ^ | ||
| Last Update Date | 2025-03-03 | 2024-04-03 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
|---|---|---|---|---|
| Total Assets | 5,161,985 | 5,251,980 | 4,979,766 | 4,986,420 |
| Total Liabilities | 3,415,769 | 3,570,654 | 3,361,939 | 3,428,705 |
| Total Shareholders Equity (After Deducting the Minority Equity) | 1,699,328 | 1,636,633 | 1,572,117 | 1,510,009 |
| Total Liabilities and Shareholders Equity | 5,161,985 | 5,251,980 | 4,979,766 | 4,986,420 |
| Statement of Income | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
| Total Revenue (Sales/Operating) | 732,074 | 712,657 | 689,210 | 671,047 |
| Net Profit (Loss) before Zakat and Tax | 72,727 | 68,435 | 59,167 | 58,028 |
| Zakat and Income Tax | -10,983 | -7,264 | -7,224 | -4,725 |
| Net Profit (Loss) after Zakat and Tax | 61,744 | 61,171 | 51,943 | 53,303 |
| Total Comprehensive Income | 62,696 | 64,515 | 53,038 | 54,125 |
| Profit (Loss) per Share | 0.67 | 0.66 | 0.56 | 0.58 |
| Cash Flows | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
| Net Cash From Operating Activities | 637,635 | 239,912 | 197,996 | 163,891 |
| Net Cash From Investing Activities | -434,685 | -115,135 | -37,873 | -185,141 |
| Net Cash From Financing Activities | -197,509 | -96,892 | -182,873 | 70,862 |
| Cash and Cash Equivalents, Beginning of the Period | 44,423 | 44,423 | 44,423 | 15,602 |
| Cash and Cash Equivalents, End of the Period | 49,864 | 72,308 | 21,673 | 65,214 |
| All Figures in | Thousands | Thousands | Thousands | Thousands |
| All Currency In | ^ | ^ | ^ | ^ |
| Last Update Date | 2024-11-04 | 2024-08-04 | 2024-05-05 | 2023-11-05 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
Display Previous Periods
Jump To:
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Jump To:
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Jump To:
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
Construct, manage, operate and maintenance for hospitals, clinics, centers, institutes, rehabilitation centers, physiotherapy, laboratory, X-Ray, pharmacies, purchasing of lands to construct buildings and investment for the company in medical projects
Company History
Middle East Healthcare Company (MEAHCO) is a closed joint stock company incorporated pursuant to the Ministerial Resolution number 2554 dated 16/03/1425H (corresponding to 05/05/2004G) and registered under commercial registration number 4030149460 dated 06/04/1425H (corresponding to 25/05/2004G) with a paid-up share capital of (SAR 590000000) five hundred and ninety million Saudi Riyals, of which (SAR 42040000) forty-two million and forty thousand Saudi Riyals were paid through cash contributions, while the remaining (SAR 547960000) five hundred and forty seven million and nine hundred and sixty thousand Saudi Riyals were paid through in kind contributions made by BAB consisting of SGH Madinah (including its land and buildings) SGH Aseer (including its land and buildings) and shares representing 80% of the share capital of BABAS (former owner and operator of SGH Riyadh) On 02/02/1435H (corresponding to 5/12/2013G) the EGA of the Company agreed to increase the Companies share capital from (SAR 590000000) five hundred ninety million Saudi Riyals to (SAR 767000000) seven hundred sixty seven million Saudi Riyals The increase of (SAR 177000000) one hundred and seventy seven million Saudi Riyals was covered through capitalization of the Shareholders account that resulted from their offering of additional in kind contributions to the Company which consisted of the following 1 SGH Jeddah 2 98% of the shares of AJ Sons 3 39.96% of NHCs share capital 4 Management Supervision Agreements for hospitals owned by third parties outside the Kingdom located in Dubai (UAE) Cairo (Egypt) and Sanaa (Yemen) 5 20% of BABAS which resulted in the Company fully owning BABAS and therefore fully owning SGH Riyadh which was later converted into a fully owned branch by the Company under commercial registration number 1010162269 dated 24/07/1421H (corresponding to 21/10/2000G) and a plot of land in the city of Dammam with a surface area of (30,000) thirty thousand m2 (Dammam Land) On 28/7/1436H (corresponding to 17/5/2015G) the EGA agreed to further increase the Companies share capital from (SAR 767000000) seven hundred and sixty-seven million Saudi Riyals to (SAR 920400000) nine hundred and twenty million four hundred thousand Saudi Riyals The increase of (SAR 153400000) one-hundred and fifty-three million four hundred thousand Saudi Riyals was covered through capitalization of the retained earnings account
Company Bylaws
Click here
Equity Profile
- Authorized Capital (^) 920,400,000
- Issued Shares 92,040,000
- Paid Capital (^) 920,400,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2016-03-28
Investment limits
There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on the company's bylaw and the issued instructions by the related regulators and supervisory authorities.
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
-
Date Established
2004/05/05
-
Financial Year End
31/12
-
Listing Date
2016/03/29
-
External Auditors
[Ernst & Young (EY)]
-
ISIN CODE
SA141H01UKH9
-
Number of Employees
4322
-
Chairman
SOBHI ABDULJALEEL A. BATTRJEE
Non - ExecutiveSOBHI ABDULJALEEL A. BATTRJEE
-
BD Session Start
2020-09-17
Designation
Chairman
-
BD Session End
2023-09-16
Classification
Non - Executive
-
Qualification
Master degree in Electrical Engineering University of Colorado United States of America 1973G. Bachelor degree in Electrical Engineering, University of Kansas United States of America 1972G
Companies Membership
-
Memebrship Name
NATIONAL HAIL CO. FOR HEALTHCARE
Start Date
2007-07-16
Memebrship Character
Non executive
End Date
2018-11-06
-
Memebrship Name
BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
Start Date
2015-08-11
Memebrship Character
Non executive
End Date
2020-08-10
-
-
Board of Directors
Makarem Sobhi A. Batterjee Non - Executive
Makarem Sobhi A. Batterjee
-
BD Session Start
2020-09-17
Designation
Board of Directors
-
BD Session End
2023-09-16
Classification
Non - Executive
-
Qualification
Executive MBA From London Business School
Companies Membership
-
Memebrship Name
NATIONAL HAIL CO. FOR HEALTHCARE
Start Date
2007-07-16
Memebrship Character
Non executive
End Date
2018-11-06
-
Memebrship Name
BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
Start Date
2015-08-11
Memebrship Character
Non executive
End Date
2020-08-10
Khalid Abduljaleel Ibrahim Batterjee Non - Executive
Khalid Abduljaleel Ibrahim Batterjee
-
BD Session Start
2020-09-17
Designation
Board of Directors
-
BD Session End
2023-09-16
Classification
Non - Executive
-
Qualification
PhD in Human Medicine University of Essen Germany 1985G. Bachelor degree in Human Medicine and Practical Training University of Vienna Austria 1978G.
Companies Membership
-
Memebrship Name
NATIONAL HAIL CO. FOR HEALTHCARE
Start Date
2007-07-16
Memebrship Character
Non executive
End Date
2018-11-06
-
Memebrship Name
BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
Start Date
2015-08-11
Memebrship Character
Non executive
End Date
2020-08-10
Mohammed Abdulrahman Moumena Independent
Mohammed Abdulrahman Moumena
-
BD Session Start
2020-09-17
Designation
Board of Directors
-
BD Session End
2023-09-16
Classification
Independent
-
Qualification
a degree in Marketing from King Fahad University of Petroleum
Companies Membership
-
Memebrship Name
company of Alkhabeer Capital
Start Date
2012-01-01
Memebrship Character
Non Executive
End Date
2018-01-01
AMR MOHAMED KHALID KHASHOGGI Independent
AMR MOHAMED KHALID KHASHOGGI
-
BD Session Start
2020-09-17
Designation
Board of Directors
-
BD Session End
2023-09-16
Classification
Independent
-
Qualification
MBA Business Administration Yale University, School of Management New Haven CT USA Year of Graduate: 1979 B.S. Business Administration Menlo College SBA Menlo Park CA USA Year of Graduate: 1977.
Companies Membership
-
Memebrship Name
Al Ahli Takaful Company
Start Date
2010-01-01
Memebrship Character
Independent
End Date
2019-07-31
Sultan Sobhi A. Batterjee Non - Executive
Sultan Sobhi A. Batterjee
-
BD Session Start
2020-09-17
Designation
Board of Directors
-
BD Session End
2023-09-16
Classification
Non - Executive
-
Qualification
Real Estate Executive Masters Program at HARVARD University in 2017 Regents Business School London Bachelors degree in International Finance and Accounting
Companies Membership
-
Memebrship Name
BATTERJEE MEDICAL COLLEGE FOR SCIENCE AND TECHNOLOGY
Start Date
2015-08-11
Memebrship Character
Non Executive
End Date
2020-08-10
Mohammad Mustafa Bin Mohammad Omar Bin Siddiq Independent
Mohammad Mustafa Bin Mohammad Omar Bin Siddiq
-
BD Session Start
2020-09-17
Designation
Board of Directors
-
BD Session End
2023-09-16
Classification
Independent
-
Qualification
Bachelor degree in Public Administration - King Abdulaziz University 1400 A.H.
Companies Membership
-
Memebrship Name
Buruj Cooperative Insurance Company
Start Date
2013-01-07
Memebrship Character
Out of the board
End Date
2022-03-08
-
-
Senior Executives
AHMED MOHAMED SHEBL AHMED ELATREES CEO
AHMED MOHAMED SHEBL AHMED ELATREES
-
BD Session Start
2018-12-01
Designation
Senior Executives
-
BD Session End
-
Classification
CEO
-
Qualification
Diploma in Hospital Management American University in Cairo Egypt 2005G. Diploma in Hospital Management Ain Shams University Egypt 2004G. Diploma in Healthcare Total Quality Management American University in Cairo Egypt 2003G. Master degree in Medicine in Thoracic and Cardiovascular Surgery AlAzhar University Egypt 2003G Bachelor degree in Medicine and Surgery Tanta University Egypt 1993G
MADANI BAHYELDIN ABBAS HOZAIEN CFO
-
MADANI BAHYELDIN ABBAS HOZAIEN
-
BD Session Start
2019-06-30
Designation
Senior Executives
-
BD Session End
-
Classification
CFO
-
Qualification
2016 MBA International Paris from Paris Dauphine University together with the University of Paris1 Pantheon Sorbonne France. 2016 Master in Economy from the University of Paris1 Pantheon Sorbonne France 2005 Diploma in Finance from the Arab Academy for Science and Technology (AAST) Cairo Egypt 1990 Diploma in Superieur de francais des Affaires de la Chamber de Commerce et d Industries de Paris 1987 B.Sc. of Commerce (Accounting) from Ain Shams University Cairo Egypt
Investor Relations
Contact Name:
MUATH MOHAMMED ALZARKAN
Company Address:
Jeddah, Batterjee Street, Al Zahra District P.O.BOX2550 Jeddah 21461
Contact Details:
Telephone:0966-12-2606000
Fax: 00966-12-6835874
Email: president4@sghgroup.net
Company Website:
Add To Watchlist
In your Watchlist
Add To Watchlist
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
